Amrutanjan Health Care Ltd vs Gland Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Amrutanjan Health Care Ltd is ₹ 556.05 as of 18 May 15:30 . The P/E Ratio of Amrutanjan Health Care Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Gland Pharma Ltd changed from 40.7 on March 2021 to 37.5 on March 2025 . This represents a CAGR of -1.62% over 5 years The Market Cap of Amrutanjan Health Care Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Market Cap of Gland Pharma Ltd changed from ₹ 40535 crore on March 2021 to ₹ 26232 crore on March 2025 . This represents a CAGR of -8.34% over 5 years The revenue of Amrutanjan Health Care Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Gland Pharma Ltd for the Mar '26 is ₹ 1854 crore as compare to the Dec '25 revenue of ₹ 1758 crore. This represent the growth of 5.44% The ebitda of Amrutanjan Health Care Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Gland Pharma Ltd for the Mar '26 is ₹ 624.49 crore as compare to the Dec '25 ebitda of ₹ 473.7 crore. This represent the growth of 31.83% The net profit of Amrutanjan Health Care Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% The net profit of Gland Pharma Ltd changed from ₹ 143.76 crore to ₹ 366.68 crore over 8 quarters. This represents a CAGR of 59.71% The Dividend Payout of Amrutanjan Health Care Ltd changed from 20.04 % on March 2021 to 26.15 % on March 2025 . This represents a CAGR of 5.47% over 5 yearsThe Dividend Payout of Gland Pharma Ltd changed from 31.57 % on March 2024 to 27.22 % on March 2025 . This represents a CAGR of -7.14% over 2 years .

About Amrutanjan Health Care Ltd

Amrutanjan Health Care Limited (AHCL) was incorporated on September 9, 1936 in Chennai, Tamil Nadu.
The Chennai-based Amrutanjan manufactures bulk drugs and drug intermediates like theophylline, based on in-house research.
Three plants have been set up in the Alandur industrial belt near Chennai to produce these products.
It recently entered into a joint venture with Welsh firm Cardiff Chemicals to manufacture pheromones (a type of agrochemicals) at Cuddalore.
Pheromones have found wide application as pesticides and are used on cotton crops.

About Gland Pharma Ltd

Gland Pharma Limited was incorporated as Gland Pharma Private Limited', a private limited company on March 20, 1978 and was granted the certificate of incorporation by Registrar of Companies, Andhra Pradesh at Hyderabad.
Subsequently, the name of the Company was changed to Gland Pharma Limited' and a fresh certificate of incorporation dated April 25, 1995 was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
The Company is primarily engaged in manufacturing injectable formulations. Established in Hyderabad, India, Company has evolved into a prominent entity in the global generic injectables market, with operations extending to over 60 countries including the United States, Europe, Canada, Australia, and India.
Primarily functioning under a B2B model, the company provides comprehensive services such as contract development, dossier compilation, technology transfer, and manufacturing across various delivery systems.

FAQs for the comparison of Amrutanjan Health Care Ltd and Gland Pharma Ltd

Which company has a larger market capitalization, Amrutanjan Health Care Ltd or Gland Pharma Ltd?

Market cap of Amrutanjan Health Care Ltd is 1,607 Cr while Market cap of Gland Pharma Ltd is 35,574 Cr

What are the key factors driving the stock performance of Amrutanjan Health Care Ltd and Gland Pharma Ltd?

The stock performance of Amrutanjan Health Care Ltd and Gland Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Amrutanjan Health Care Ltd and Gland Pharma Ltd?

As of May 18, 2026, the Amrutanjan Health Care Ltd stock price is INR ₹556.05. On the other hand, Gland Pharma Ltd stock price is INR ₹2159.2.

How do dividend payouts of Amrutanjan Health Care Ltd and Gland Pharma Ltd compare?

To compare the dividend payouts of Amrutanjan Health Care Ltd and Gland Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.